Important dates:

  • Early bird registration2 January 2017
  • Abstract submission20 January 2017
  • Paper submission20 January 2017
  • Standard registration3 February 2017

Synopsis
The aim of the 6th RSC-BMCS Fragment-based Drug Discovery meeting will be to continue the focus on case studies in Fragment-based Drug Discovery that have delivered compounds to late stage medicinal chemistry, preclinical or clinical programmes. The Fragment series was started in 2007 and continues with the theme, having over three-quarters of the presentations focused on case studies. The conference will include successful examples from all types of fragment-based approaches, including high concentration, NMR, SPR and X-ray screening.

Who should attend
This conference is suitable for scientists including all chemists as well as other important disciplines including biophysics, structural biology, etc. This international meeting attracts delegates from the UK, several mainland European countries, as well as from the USA, Japan, China and South Korea.

Related Events

Comments